Black Rock Inc. Roivant Sciences Ltd. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
361Shares Held
456MCall Options Held
8.34MPut Options Held
720K-
Sb Investment Advisers (Uk) LTD London, X060MShares$694 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$517 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$455 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$396 Million1.22% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$340 Million32.33% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...